Trials / Completed
CompletedNCT00258622
NS1209 and Lidocaine in Patients With Peripheral Neuropathic Pain
NS1209 and Lidocaine in Patients With Peripheral Neuropathic Pain: a Randomized, Double-Blind, Placebo-Controlled, Crossover Study
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 18 (actual)
- Sponsor
- Danish Pain Research Center · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Purpose: To evaluate the efficacy, tolerability and safety of NS1209 compared to lidocaine and placebo in patients with peripheral chronic neuropathic pain.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | NS1209 | |
| DRUG | Lidocaine |
Timeline
- Start date
- 2005-11-01
- Completion
- 2007-02-01
- First posted
- 2005-11-28
- Last updated
- 2007-11-16
Locations
1 site across 1 country: Denmark
Source: ClinicalTrials.gov record NCT00258622. Inclusion in this directory is not an endorsement.